Business Wire

MN-CARLSON/REZIDOR

Share
Rezidor and Carlson Hotels Announce New Organizational Structure

The Rezidor Hotel Group (“Rezidor”) and Carlson Hotels, Inc. (“Carlson Hotels”) today announced that they will create a Global Steering Committee to provide overall strategic direction to both companies. The Committee will be comprised of an equal number of representatives from Carlson Hotels and Rezidor, and will provide guidance and strategic counsel to the respective management teams of Carlson Hotels and Rezidor. Both Carlson Hotels and Rezidor will continue to operate as independent entities and the companies will continue to be governed and led by each company’s respective Boards of Directors and key executives. The creation of a new Global Steering Committee has been approved by the Boards of Directors of both companies.

As part of the new structure, Rezidor separately announced that Federico González Tejera has resigned as Global Chief Executive Officer of Carlson Hotels Group and has been named President & CEO of Rezidor. Mr. González will also serve as Chairman of the Global Steering Committee. Wolfgang M. Neumann has resigned as President & CEO of Rezidor and will serve as a non-executive Director on the Rezidor Board of Directors. John Kidd will become Chief Executive Officer of Carlson Hotels.

Charles Mobus, Director of the Rezidor Board and Director of the Carlson Hotels Board, said, “Rezidor and Carlson Hotels share a rich history, and their partnership remains an important component to both companies’ global success. Over the past few months, Rezidor and Carlson Hotels have carefully studied the ways in which the companies’ relationship can be enhanced in order to maximize value and growth potential. As a result, the Boards of Directors of both companies have determined that this new strategic approach will enable both Rezidor and Carlson Hotels to deliver improved results by better capitalizing on their existing relationship and maximizing the potential of their combined international footprint.”

Mr. González said, “Rezidor’s relationship with Carlson Hotels creates numerous opportunities for growth and success. The establishment of a Global Steering Committee will ensure that both businesses are in lock-step and are able to make more informed decisions that will benefit each entity and the Carlson-Rezidor family as a whole. As CEO of Rezidor, and in close collaboration with the Steering Committee, I believe that we can realize tremendous value for Rezidor’s shareholders and both companies’ customers and employees.”

The Global Steering Committee:

The Global Steering Committee will foster deeper and more effective collaboration between the two companies in order to improve decision-making processes and productivity, ensure greater strategic alignment, and leverage the talent of both organizations. As part of its mandate, the Committee will:

  • Provide overall strategic guidance and counsel to each company’s management teams;
  • Provide insight on key global functions within Carlson Hotels and Rezidor, including branding, marketing & sales, IT, and other global resources; and,
  • Refine partner and franchisee alignment to better reflect the needs of both companies and their customers.

According to the founding charter, the Committee will be comprised of the following positions:

  • Rezidor Representatives: President & CEO, and Deputy President & Chief Financial Officer
  • Carlson Hotels Representatives: Chief Executive Officer, and Chief Information Officer
  • Global Representatives of Rezidor and Carlson Hotels: Executive Vice President & Global Chief Branding and Commercial Officer, and Executive Vice President & Global Chief Resources Officer

About The Rezidor Hotel Group

The Rezidor Hotel Group is one of the most dynamic hotel companies in the world and a member of the Carlson Rezidor Hotel Group. The group features a portfolio of more than 480 hotels in operation or under development with 105,000 rooms in 80+ countries.

Rezidor operates the core brands Radisson Blu® and Park Inn® by Radisson in Europe, the Middle East and Africa (EMEA), along with the Club CarlsonSM loyalty program for frequent hotel guests. In early 2014 and together with Carlson, Rezidor launched the new brands Radisson RED (lifestyle select) and Quorvus Collection (luxury). In 2016, Rezidor acquired 49% of prizeotel. Rezidor has an industry-leading Responsible Business Program and was named one the World's Most Ethical Companies by the US think-tank Ethisphere.

In November 2006, Rezidor was listed on the Nasdaq Stockholm, Sweden.

The Rezidor Hotel Group and its brands employ 43,700 people in EMEA and is headquartered in Brussels, Belgium.

About Carlson Hotels, Inc.

Carlson Hotels is one of the world’s largest and most dynamic hotel groups and includes 1,440 hotels in operation and under development with more than 230,000 rooms and a footprint spanning 115 countries and territories. The Carlson Hotels portfolio includes a powerful set of global brands: Quorvus Collection, Radisson Blu® , Radisson® , Radisson RED, Park Plaza® ; Park Inn® by Radisson, Country Inns & Suites By CarlsonSM and Club CarlsonSM , the global hotel rewards program.

Contact:

For Rezidor:
Lucie Cardona, Director Media Relations & Reputation Management
lucie.cardona@carlsonrezidor.com
or
For Carlson Hotels:
Sard Verbinnen & Co.
Michael Henson/Elizabeth Smith
+44 (0)20 3178 8914
or
Brandon Messina
+1 212 687 8080

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye